Triple-negative breast cancer (TNBC) is used to describe a subset of breast cancers and is defined as the lack of expression of estrogen receptor (ER) and progesterone receptor (PR) and the absence of human epidermal growth factor receptor 2 (HER2) overexpression and/or gene amplification 1. Here, ERBB2 is linked to breast cancer.